Vimarsana
Biggest News Aggregation in the World

Page 3 - Plus Drug News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Plus Drug. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Plus Drug Today - Breaking & Trending Today

Mark Cuban's pharmacy could have saved Medicare $3.6 billion, researchers find - Vimarsana News

Mark Cuban's pharmacy could have saved Medicare $3.6 billion, researchers find

Medicare could have saved $3.6 billion in a single year if it had bought generic drugs from Mark Cuban’s online pharmacy, according to a Harvard University report. In the report published this week in Annals of Internal Medicine, researchers from Brigham’s and Women’s Hospital with the Harvard Medical School made

Medicare Could Save Billions on Generic Drugs Buying at Mark Cuban's Prices - Vimarsana News

Medicare Could Save Billions on Generic Drugs Buying at Mark Cuban's Prices

Researchers compared what the U.S. government pays for prescription drugs to the prices of generic drugs sold at the entrepreneur’s new online pharmacy.

Mark Cuban's New Company Has 2 Words for the Pharmaceutical Industry: A Lesson in Empathy, Leadership, and Emotional Intelligence - Vimarsana News

Mark Cuban's New Company Has 2 Words for the Pharmaceutical Industry: A Lesson in Empathy, Leadership, and Emotional Intelligence

 Getty Images Starting a business that charges lower prices and that -- however counterintuitively -- provides a better product, service, or experience is a successful entrepreneurial strategy.  Like Uber with taxis. Aldi and grocery stores. Amazon and, well, everything. Add Mark Cuban and his just-launched Mark Cuban Cost Plus Drug Company, a pharmaceutical company that plans to make less expensive versions of selected (read: expensive) generic drugs. The company's first drug will be a generic version of albendazole, an antiparasitic drug used to treat hookworm. Treated early, two tabl...

Source: inc.com